Understanding opportunities and challenges with telemedicine-delivered buprenorphine during the COVID-19 pandemic

INTRODUCTION: Opioid use disorder (OUD) is a debilitating illness that remains a serious public health issue in the United States. Use of telemedicine to deliver medications for the treatment of OUD (MOUD) was limited until the confluence of the COVID-19 and opioid addiction epidemics in spring 2020...

Descripción completa

Detalles Bibliográficos
Autores principales: Mattocks, Kristin M., Moore, David T., Wischik, Dora Lendvai, Lazar, Christina M., Rosen, Marc I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pergamon Press 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949846/
https://www.ncbi.nlm.nih.gov/pubmed/35346533
http://dx.doi.org/10.1016/j.jsat.2022.108777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949846/
https://www.ncbi.nlm.nih.gov/pubmed/35346533
http://dx.doi.org/10.1016/j.jsat.2022.108777

Ejemplares similares